We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other ...

当地时间4月15日，Mural Oncology宣布终止其新型免疫疗法nemvaleukin的所有临床开发计划，并裁员90%。该决定是在对黑色素瘤II期ARTISTRY-6研究和铂耐药卵巢癌III期ARTISTRY-7研究数据进行评估后做出的。尽管这一壮举似乎相当反常，但Mural的股价却强劲上涨，收盘时飙升134%至4152.01万美元。